GlobeNewswire Inc.··NaSerina Therapeutics Unveils PEG-Free LNP Technology at Industry Summit
Serina's Chief Development Officer to present novel POZ-based lipid nanoparticles that eliminate PEG immunogenicity issues, showing no antibody response in preclinical studies.
PFESERbiotechnologydrug delivery